Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/15/2025

Kawasaki Disease Diagnosis and Clinical Features

Introduction to Kawasaki Disease

  • The American Heart Association recommends that in a 1-year-old with suspected Kawasaki disease, the polymorphous rash typically appears as erythematous maculopapular lesions that are truncal with groin accentuation, but extremity involvement manifests primarily as acute erythema and edema of the hands and feet with sharp demarcation at the wrists and ankles 1, 2

Clinical Features of Kawasaki Disease

  • The American Academy of Family Physicians notes that the rash presents in several accepted forms, including erythematous maculopapular eruption, diffuse erythroderma, erythema multiforme-like pattern, and urticarial or scarlatiniform appearance 2, 3
  • The rash typically appears within the first 5 days of fever onset and shows truncal distribution with particular accentuation in the groin/perineal region 2, 3
  • The American College of Cardiology states that the extremities in Kawasaki disease show distinct changes, including erythema of palms and soles with sharp demarcation at wrists and ankles, and edema of hands and feet that may be painful and shows clear boundaries at the joints 1, 2, 4
  • The American Academy of Pediatrics recommends that during the convalescent phase (2-3 weeks after onset), patients may experience membranous desquamation starting in the periungual region of fingers and toes 1, 2, 4

Diagnostic Criteria for Kawasaki Disease

  • The American Heart Association recommends that the diagnosis requires fever ≥5 days plus ≥4 of 5 principal features: polymorphous exanthem, bilateral conjunctival injection, oral/lip changes, extremity changes, and cervical lymphadenopathy 1, 4
  • Incomplete Kawasaki disease is more common in infants under 1 year, who may present with fewer than 4 of the 5 principal features 3

Treatment and Prognosis of Kawasaki Disease

  • The American Academy of Family Physicians notes that early recognition is critical, and treatment with IVIG within 10 days of fever onset reduces coronary artery abnormality risk from 25% to approximately 5% 3

Clinical Presentation of Polymorphous Rash in Kawasaki Disease

Primary Characteristics

  • The polymorphous rash in Kawasaki disease appears as a maculopapular, diffuse erythroderma, or erythema multiforme-like eruption that can vary significantly in appearance between patients, often with perineal accentuation and early desquamation in that region 5, 6
  • The American Heart Association notes that the rash can present in three distinct forms, all considered diagnostic: maculopapular, diffuse erythroderma, and erythema multiforme-like 5, 6

Key Distinguishing Features

  • The term "polymorphous" refers to the variability in appearance between different patients, not necessarily multiple morphologies in the same patient, as stated by the American College of Cardiology 7
  • Critical characteristics that help identify this rash include perineal involvement, which frequently shows accentuation in the perineal region with early desquamation, according to the American Academy of Pediatrics 8
  • The rash typically appears within the first 5 days of fever onset, as recommended by the American Heart Association 7, 9

Clinical Context and Diagnostic Pitfalls

  • The diagnosis of Kawasaki disease requires fever ≥5 days plus ≥4 of the 5 features, including the polymorphous exanthem, bilateral conjunctival injection, oral/lip changes, extremity changes, and cervical lymphadenopathy, as stated by the American College of Cardiology 5, 6
  • The American Heart Association notes that the rash must be interpreted within the complete clinical picture, and early treatment (within 10 days of fever onset) is critical to prevent coronary artery aneurysms 5, 9